These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 20127093)

  • 1. Biology of interleukin-22.
    Wolk K; Witte E; Witte K; Warszawska K; Sabat R
    Semin Immunopathol; 2010 Mar; 32(1):17-31. PubMed ID: 20127093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells.
    Wolk K; Sabat R
    Cytokine Growth Factor Rev; 2006 Oct; 17(5):367-80. PubMed ID: 17030002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biology and functions of Th22 cells.
    Jia L; Wu C
    Adv Exp Med Biol; 2014; 841():209-30. PubMed ID: 25261209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic opportunities of the IL-22-IL-22R1 system.
    Sabat R; Ouyang W; Wolk K
    Nat Rev Drug Discov; 2014 Jan; 13(1):21-38. PubMed ID: 24378801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-22: a likely target for treatment of autoimmune diseases.
    Yang X; Zheng SG
    Autoimmun Rev; 2014 Jun; 13(6):615-20. PubMed ID: 24418299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology of IL-21 and the IL-21 receptor.
    Mehta DS; Wurster AL; Grusby MJ
    Immunol Rev; 2004 Dec; 202():84-95. PubMed ID: 15546387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs: New regulators of IL-22.
    Lu Z; Liu R; Huang E; Chu Y
    Cell Immunol; 2016; 304-305():1-8. PubMed ID: 27221197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells.
    Kamiya S; Owaki T; Morishima N; Fukai F; Mizuguchi J; Yoshimoto T
    J Immunol; 2004 Sep; 173(6):3871-7. PubMed ID: 15356135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis.
    Bauer JH; Liu KD; You Y; Lai SY; Goldsmith MA
    J Biol Chem; 1998 Apr; 273(15):9255-60. PubMed ID: 9535918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.
    Nagalakshmi ML; Rascle A; Zurawski S; Menon S; de Waal Malefyt R
    Int Immunopharmacol; 2004 May; 4(5):679-91. PubMed ID: 15120652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Does Interleukin-22 Mediate Liver Regeneration and Prevent Injury and Fibrosis?
    Khawar MB; Azam F; Sheikh N; Abdul Mujeeb K
    J Immunol Res; 2016; 2016():2148129. PubMed ID: 28050571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures and biological functions of IL-31 and IL-31 receptors.
    Zhang Q; Putheti P; Zhou Q; Liu Q; Gao W
    Cytokine Growth Factor Rev; 2008; 19(5-6):347-56. PubMed ID: 18926762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses.
    Parrish-Novak J; Foster DC; Holly RD; Clegg CH
    J Leukoc Biol; 2002 Nov; 72(5):856-63. PubMed ID: 12429707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2.
    Sheikh F; Baurin VV; Lewis-Antes A; Shah NK; Smirnov SV; Anantha S; Dickensheets H; Dumoutier L; Renauld JC; Zdanov A; Donnelly RP; Kotenko SV
    J Immunol; 2004 Feb; 172(4):2006-10. PubMed ID: 14764663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection.
    Witte E; Witte K; Warszawska K; Sabat R; Wolk K
    Cytokine Growth Factor Rev; 2010 Oct; 21(5):365-79. PubMed ID: 20870448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-26, a highly cationic T-cell cytokine targeting epithelial cells.
    Braum O; Pirzer H; Fickenscher H
    Antiinflamm Antiallergy Agents Med Chem; 2012; 11(3):221-9. PubMed ID: 23106140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-24 and its receptors.
    Wang M; Liang P
    Immunology; 2005 Feb; 114(2):166-70. PubMed ID: 15667561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis and other Th17-mediated skin diseases.
    Tokura Y; Mori T; Hino R
    J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.